TBI is a form of acquired brain injury resulting from sudden trauma to the head. Symptoms of TBI can range from mild, to moderate, to severe. A person with mild TBI (mTBI) may or may not experience a loss of consciousness. Other symptoms of mTBI include headache, confusion, lightheadedness, dizziness, blurry vision, tinnitus, dysgeusia, fatigue, changes in sleep patterns or behavior, and impairment of memory or cognition.
Since an accurate diagnosis is key in determining the management and predicting the outcome of patients with head trauma, it is important to use all modalities available for diagnosis, specifically DTI. Accurate diagnosis of brain injuries is critical. Without it, medical professionals cannot take steps forward to help patients.
Traditional methods of imaging brain disorders are largely insufficient; they may lack diagnostic specificity, which leads to errors and delays in diagnosis while frequently missing critical treatment windows. Advanced MR imaging expands the range of tissue properties “visible” to a clinician, including the detection of important biomarkers and the imaging of tissue function. These capabilities provide enhanced diagnostic capabilities, more rigorous ways of determining treatment parameters, and measuring response to treatment.
The medical team at CNS has changed the landscape for people suffering with mild– to moderate–TBI. From sports-related concussions, to assaults, to motor vehicle accidents, CNS research has successfully shown that advanced MRI imaging is far more sensitive than clinical imaging standards.
Our team has presented their work in high-visibility journals, scientific conferences, and before National Institutes of Health and Department of Defense-sponsored workshops. They have testified before Congress on brain injury in NFL players after studying 45 former players in an NFL-sponsored study. The advanced MR imaging available at CNS has been admissible in court as material evidence, often tilting the balance of cases. Their ground-breaking work will become the standard for confirming the diagnosis and prognosis of mild brain injury and ensuring maximum outcome.